Abstract
Preclinical and clinical issues in Alzheimer's disease drug research and development.
Highlights
Alzheimer’s disease (AD) is a chronic, rapidly progressive neurodegenerative disease, characterized by loss of memory and cognitive abilities, inability to carry out regular daily activities and mental disorders
This Research Topic has been designed as a platform to analyze some of the most relevant problems posed by research on AD, suggest and develop new ideas that may improve both preclinical and clinical research on this disease
The complexity of the events that determine the onset and progression of AD is emphasized by the many factors that contribute to the pathogenesis of this disease
Summary
Alzheimer’s disease (AD) is a chronic, rapidly progressive neurodegenerative disease, characterized by loss of memory and cognitive abilities, inability to carry out regular daily activities and mental disorders. This Research Topic has been designed as a platform to analyze some of the most relevant problems posed by research on AD, suggest and develop new ideas that may improve both preclinical and clinical research on this disease.
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
